ArticleeLife2019
TLE3 loss confers AR inhibitor resistance by facilitating GR-mediated human prostate cancer cell growth.
Sander Al Palit et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
26 papers cite it
this paperpooled itcites it